GILD
Gilead's first quarter 2026 revenue of $7.0B beat estimates, driven by 10% growth in its HIV franchise.
Gilead reported first quarter revenue of $7.0 billion and non-GAAP EPS of $2.03, beating analyst estimates. Results were driven by strong growth in the HIV and...